NCT00692770 - Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM) | Biotech Hunter

Enrollment

1,114

Participants

Timeline

Start Date

August 15, 2008

Primary Completion Date

November 29, 2013

Study Completion Date

November 28, 2014

Conditions

Carcinoma, Hepatocellular

Interventions

DRUG

Nexavar (Sorafenib, BAY43-9006)

Sorafenib 400 mg twice daily (BID)

DRUG

Placebo

Placebo 2 tablets twice daily (BID)

Trial Locations (199)

100

Taipei

112

Taipei

333

Taoyuan District

704

Tainan City

807

Kaohsiung City

833

Kaohsung

1023

Auckland

1090

Vienna

1200

Bruxelles - Brussel

2010

Varna

2031

Randwick

2050

Camperdown

3000

Leuven

3004

Melbourne

3010

Bern

3084

Heidelberg

4000

Liège

4002

Plovdiv

4020

Linz

4120

Brisbane

6020

Innsbruck

8091

Zurich

9000

Ghent

10029

New York

10126

Turin

12200

Berlin

13005

Marseille

14004

Córdoba

14050

México, D.F.

14080

México, D.F.

15213

Pittsburgh

20007

Washington D.C.

20121

Milan

20133

Milan

20246

Hamburg

21287

Baltimore

23249

Richmond

28007

Madrid

28040

Madrid

28222

Majadahonda

30322

Atlanta

30625

Hanover

31059

Toulouse

33000

Bordeaux

33011

Oviedo

33136

Miami

35000

Rennes

35128

Padua

37075

Göttingen

39120

Magdeburg

40138

Bologna

40202

Louisville

40225

Düsseldorf

41124

Modena

43210

Columbus

44106

Cleveland

44195

Cleveland

45147

Essen

46202

Indianapolis

47012

Valladolid

48109

Ann Arbor

48903

Cruces/Barakaldo

49241

Busan

49933

Angers

50937

Cologne

52074

Aachen

54500

Vandœuvre-lès-Nancy

55131

Mainz

55407

Minneapolis

55455

Minneapolis

59037

Lille

64710

Monterrey

66421

Homburg/Saar

69004

Lyon

70112

New Orleans

70124

Bari

75020

Paris

75571

Paris

77030

Houston

80123

Napoli

80131

Napoli

81377

München

81675

München

82100

Benevento

85054

Phoenix

90033

Los Angeles

90127

Palermo

93042

Regensburg

93143

Bondy

94010

Créteil

94115

San Francisco

94800

Villejuif

95122

Catania

97213

Providence Portland Medical Center, Portland

97239

Portland

98101

Seattle

98109

Seattle

100021

Beijing

100071

Beijing

100142

Beijing

Beijng

100853

Beijing

115478

Moscow

116027

Dalian

119228

Singapore

119991

Moscow

169608

Singapore

197758

Saint Petersburg

200001

Shanghai

200438

Shanghai

210002

Nanjing

230022

Hefei

249036

Obninsk

300060

Tianjin

400015

Cluj-Napoca

400038

Chongqing

410008

Changsha

410013

Changsha

430022

Wuhan

510060

Guangzhou

510080

Guangzhou

510515

Guangzhou

530021

Nanning

610041

Chengdu

610072

Chengdu

700106

Iași

700721

Daegu

710038

Xi’an

710061

Xi’an

710068

Xi’an

35294-3300

Birmingham

90095-7077

Los Angeles

02114

Boston

02215

Boston

01805

Burlington

B1629ODT

Pilar

C1181ACH

Buenos Aires

S2002KDS

Rosario

90035-903

Porto Alegre

90470 340

Porto Alegre

90610-000

Porto Alegre

01323-001

São Paulo

01246-903

São Paulo

T2N 4N1

Calgary

T6G 1Z2

Edmonton

V5Z 4E6

Vancouver

K1H 8L6

Ottawa

M5G 2M9

Toronto

Unknown

Reñaca

Hong Kong

Kwun Tong

Shatin

833-0024

Santiago

06202

Nice

06120

Halle

115 27

Athens / Greece

00168

Rome

09134

Cagliari

277-8577

Kashiwa-shi

920-8641

Kanazawa

232-0024

Yokohama

589-8511

Osakasayama-shi

565-0871

Suita

113-8655

Bunkyo-ku

104-0045

Chuo-ku

173-8610

Itabashi-ku

105-8470

Minato-ku

150-8935

Shibuya-ku

162-8666

Shinjuku-ku

812-8582

Fukuoka

860-8556

Kumamoto

606-8507

Kyoto

700-8558

Okayama

537-8511

Osaka

770-8503

Tokushima

3000-075

Coimbra

022326

Bucharest

410-769

Goyang-si

411-706

Goyang-si

135-720

Seoul

561-712

Jeollabuk-do

05505

Seoul

110-744

Seoul

120-752

Seoul

135-710

Seoul

08208

Sabadell

08035

Barcelona

06080

Badajoz

08036

Barcelona

413 45

Gothenburg

141 86

Stockholm

500-06

Changhua

SO16 6YD

Southampton

B15 2TT

Birmingham

LS9 7TF

Leeds

NW3 2QG

London

SE5 9RS

London

M20 4BX

Manchester

NE7 7DN

Newcastle upon Tyne